Pascal Soriot, Len Schleifer, Paul Perreault
October 23, 2019 07:08 AM EDTUpdated 07:24 AM
People

So­ri­ot, Schleifer, Per­reault named top glob­al CEOs — but gone are phar­ma's gold­en years

Amber Tong

CEOs of gi­ant com­pa­nies can be re­mem­bered for a pletho­ra of things: the deals they strike, the peo­ple they hire and fire, the words they …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: Am­gen obe­si­ty shot shows 20% weight loss, but dos­ing ques­tions hang over read­out

The Biden ad­min­is­tra­tion wants Medicare and Med­ic­aid to cov­er GLP-1s. Will the Trump White House al­low it?

Sarep­ta li­cens­es Ar­row­head­'s RNA-based rare dis­ease pipeline, promis­ing big biobucks

Up­dat­ed: Roche buys out CAR-T part­ner Po­sei­da for $1B up­front

Ax­some moves to­ward NDA fil­ing for nar­colep­sy drug fol­low­ing pos­i­tive Phase 3 da­ta

Roche’s TIG­IT drug miss­es last shot at sur­vival end­point win in Phase 3 lung can­cer tri­al

A service from the Financial Times